Treatment With Interferon Beta-1a in Brazil Is Associated With Fewer Hospitalizations Due to Relapse, Better Adherence and a Better Response Compared to Other Platform Therapies
Value in Health- United Kingdom
doi 10.1016/j.jval.2016.03.234
Full Text
Abstract
Available in
Date
May 1, 2016
Authors
Publisher
Elsevier BV